VIM and colorectal cancer: In the present study, four of the biomarkers (CNRIP1, FBN1, MAL, and SPG20) were more frequently methylated in colorectal cancers than previously reported for the vimentin gene, and additionally less frequently methylated in normal mucosa samples, underscoring the suitability of these markers for diagnostic use.